Superselective embolization with PHIL offers a precise, minimally invasive solution for high-flow AVFs post-TMJ arthroscopy, ensuring complete occlusion while minimizing complications. This case underscores PHIL's efficacy as an advanced embolic agent for rare but critical vascular injuries, optimizing patient outcomes.
Lederman et al. (2026) studied this question.